Crinetics Pharmaceuticals Files 8-K on Shareholder Vote
Ticker: CRNX · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
Related Tickers: CRNX
TL;DR
CRNX filed an 8-K for a shareholder vote on 6/11. Nothing else major.
AI Summary
Crinetics Pharmaceuticals, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of its security holders on June 11, 2025. The filing details the company's principal executive offices located at 6055 Lusk Boulevard, San Diego, California.
Why It Matters
This filing indicates a formal process of shareholder decision-making, which can impact corporate governance and future strategic directions for Crinetics Pharmaceuticals.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not appear to contain any new material financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Date of report
- 6055 Lusk Boulevard, San Diego, California (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Crinetics Pharmaceuticals' security holders on June 11, 2025?
The filing states that matters were submitted to a vote of security holders on June 11, 2025, but the specific details of these matters are not provided in this excerpt of the 8-K.
When was the 8-K filing officially submitted to the SEC?
The 8-K filing was submitted on June 12, 2025.
What is the primary business of Crinetics Pharmaceuticals, Inc. according to the filing?
The filing lists Crinetics Pharmaceuticals, Inc. under the Standard Industrial Classification of Pharmaceutical Preparations [2834].
Where are Crinetics Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 6055 Lusk Boulevard, San Diego, California, 92121.
What is the Commission File Number for Crinetics Pharmaceuticals, Inc.?
The Commission File Number for Crinetics Pharmaceuticals, Inc. is 001-38583.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).